Menu
Not yet recruiting NCT06913283

Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure

No phase Interventional Pulpitis - Irreversible

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Pulp Therapy with Mineral trioxide aggregate (MTA), Pulp Therapy with Biodentine.
Who it may be relevant to
Registry conditions: Pulpitis - Irreversible. Basic parameters: 18 years — 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Outcome of Pulpotomy Using Mineral Trioxide Aggregate and Biodentin in the Mature Permanent Teeth With Carious Exposure

Overview

The success of pulpotomy treatment is affected by the type of biologically active material used.The effects of MTA and biodentine are compared in mature permanent teeth with caries exposure.It is expected that pulpotomy using biodentine will have a high success rate in caries exposed mature teeth compared to mineral trioxide aggregate.

Interventions

  • Procedure Pulp Therapy with Mineral trioxide aggregate (MTA)
    MTA allowed to set for twenty four hours
  • Procedure Pulp Therapy with Biodentine
    Biodentine is triturated before use

Primary outcome measures

  • Number of participants treated with MTA [Time frame: 6 months]
  • Number of Participants treated with Biodentine [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • mature permanent teeth

Exclusion criteria

  • Teeth with restorations

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Altamash Institute of Dental Medicine — Karachi

Identifiers

NCT: NCT06913283 · Altamash IDM Ambreen

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗